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Incidence and Migration
Table 1. SCD Births in Five States, 2004-2008
SCD incidence among... GA NY NC CA MI
      - All births: 1 of every: 880 1,259 1,435 5,644 2,496
      - Black/African American births: 1 of every: 295 260 360 452 467
SCD babies who are black or African American 97% 89% 95% 89% 96%
Universal newborn screening programs that test for 
particular medical conditions at birth have made it 
easier to estimate statewide incidence (number of newly 
diagnosed cases in a population) of sickle cell disease 
(SCD) for children born in the United States. However, 
using newborn screening data to estimate prevalence (total 
number of cases in a population) is imprecise because these 
programs have been in place for fewer than 20 years, and 
the average lifespan for individuals with SCD has increased 
dramatically over that time. In addition, movement of 
individuals into and out of Georgia from other states and 
countries influences state prevalence rates of SCD. 
We estimated Georgia’s 1-year and 5-year incidence of 
SCD using the state’s newborn screening data, identifying 
828 babies born from 2004 through 2008 who had positive 
screening tests for the disease. This equates to 1 out of 
every 880 babies born in Georgia during the five-year study 
period. Among black or African American babies, the rate 
was approximately 1 in 295. SCD births occurred in over 
100 of Georgia’s 159 counties during the study period (see 
map).
Georgia’s SCD incidence is shown in Table 1 in comparison 
to that of other states participating in the RuSH 
surveillance project. State rates vary by overall population 
demographics. Georgia’s SCD incidence as a proportion of 
all births is the highest of these five states. Its incidence among black or African American births is second to New York’s.
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While we have no data source that identifies 
individuals moving into the state who have 
SCD, we can estimate the percentage of 
young children with SCD living in Georgia 
during our five-year study period who were 
born in other states or countries. These 
children are included in our  data if they 
visited one of Georgia’s comprehensive sickle 
cell centers; were admitted to an emergency 
department or hospital in Georgia for SCD 
complications and used an in-state address; 
or had a medical visit for SCD paid by one 
of Georgia’s public insurance plans from 
2004-2008. By matching our confirmed and 
probable cases of SCD whose birth dates 
are in the study period with Georgia birth 
certificates and newborn screening records 
for the same time period, we developed an 
estimate of in-migration.
We found that 8 percent of the confirmed SCD cases and 10 percent of the confirmed or probable SCD cases born in this 
time period had no matching birth certificate or newborn screening record. This suggests that 8 to 10 percent of Georgia’s 
young children with sickle cell disease moved into the state after birth. 
 
By comparison, 10% of California’s confirmed SCD cases were not linked to newborn screening records; and North 
Carolina’s newborn screening follow-up program identified 14% of confirmed cases and 16% of confirmed or probable 
cases who were not born in that state. It should be noted that North Carolina’s sickle cell disease surveillance system is 
considerably more robust than Georgia’s.
Public health leaders, health care providers, and advocates for sickle cell patients in Georgia can benefit from 
understanding incidence and patterns of migration into the state by persons with SCD. This information can help them 
target outreach and treatment programs to communities with high rates of the disease and migration from high-prevalence 
areas outside of Georgia.
This project is supported by Cooperative Agreement 5U50DD001010 from the Centers for Disease Control and Prevention. Its 
contents are solely the responsibility of the authors and do not necessarily represent the official views of CDC.
Table 2. Children With SCD Born 2004-2008 Without a Matching In-State 
Birth Certificate or Newborn Screening Record
Confirmed SCD cases Confirmed or probable SCD cases
Georgia 8% 10%
North Carolina 14% 16%
California 10% Not reported
